In its second round of funding, the UW Medicine Garvey Institute for Brain Health Solutions is awarding $1.3 million for technology-driven solutions that aim to improve brain health. The technology focus was driven by the need to develop novel approaches to treat large numbers of people affected by brain disorders, as well the depth of innovation and expertise found locally.…
After more than 30 years at Fred Hutchinson Cancer Research Center, primarily studying prostate cancer genetics, risk factors and treatment outcomes, faculty member Dr. Janet Stanford has retired. She now holds the title of professor emeritus. Over her career, Stanford has made an impact both through her scientific discoveries and her leadership, said longtime research colleague Dr. Elaine Ostrander of the National Human Genome…
Today’s installment is with BBI member Dr. Sarah Leary. Dr. Leary is an attending physician in the Cancer and Blood Disorders Center at Seattle Children’s Hospital and Associate Professor of Pediatrics at the University of Washington School of Medicine. BBI: To start, could you tell us a little bit about the focus of your work, and how it relates to…
IPD researchers together with collaborators at the National Institutes of Health have developed experimental flu shots that protect animals from a wide variety of seasonal and pandemic influenza strains. The lead vaccine candidate has entered human clinical testing at the NIH. If it proves safe and effective, these next-generation influenza vaccines may replace current seasonal options by providing protection against…
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders, today announced preliminary results from the second cohort of critically ill COVID-19 patients treated with narsoplimab in Bergamo, Italy. These patients…
Our team at the Allen Institute for Brain Science studies cell type diversity in the mouse and human brains. To understand the function of the brain and how its dysfunction leads to brain diseases, an essential first step is to obtain a “parts list” of the brain, i.e. to uncover the vast range of neuronal and nonneuronal cell types and their properties and then try to understand how they work together.
Congratulations to the 2021 Chair of Medicine Scholars Award recipients. Dr. McKenna Eastment is a senior fellow/acting instructor in the Division of Allergy and Infectious Diseases. She earned her medical degree from the University of Chicago and MPH in Epidemiology from UW School of Public Health. Her clinical interests include HIV care, Infectious Diseases care, and General Internal Medicine. Dr. Leah Marcotte is an acting assistant…
Miniaturized chips containing live, human kidney cells will be on board the scheduled June 3 Space X cargo supply Mission 22 to the International Space Station. Inside the 3D chips, the cells are kept alive in a tiny system that delivers fluids dynamically. These tissue chips model responses that take place along the hard-working tubules of kidneys. The flight carrying…
Our laboratory studies the process of mRNA translation in normal cell physiology and disease. We are particularly interested in understanding how the protein and RNA components of the translation machinery interface to enable gene-specific translation. Our central hypothesis is that deregulation of translationally regulated gene networks can initiate and drive disease phenotypes such as tumorigenesis and cancer progression.
The U.S. Senate today confirmed mathematician and geneticist Eric Lander as director of the White House Office of Science and Technology Policy (OSTP). Lander will also serve as President Joe Biden’s science adviser and hold a seat in Biden’s Cabinet. Lander, 64, has long held prominent roles in U.S. research and science policy. He was president and founding director of…
